EUPROMS study first patient driven quality of life study

EUPROMS study first patient driven quality of life study

EUPROMS: prostate cancer patient-driven QoLПодробнее

EUPROMS: prostate cancer patient-driven QoL

Results from a phase I study of AMG 160Подробнее

Results from a phase I study of AMG 160

Prostate Cancer – Quality of Life - Penn State Cancer Institute 8AПодробнее

Prostate Cancer – Quality of Life - Penn State Cancer Institute 8A

The Real Burden of Prostate Cancer TreatmentПодробнее

The Real Burden of Prostate Cancer Treatment

EPAD20 Zoom LivestreamПодробнее

EPAD20 Zoom Livestream

#23034 Urinary functioning of 2943 men diagnosed and treated for prostate cancer participating i...Подробнее

#23034 Urinary functioning of 2943 men diagnosed and treated for prostate cancer participating i...

New Study Results: Prostate Cancer Part 1Подробнее

New Study Results: Prostate Cancer Part 1

Quality of life in treatment of metastatic prostate cancer patientsПодробнее

Quality of life in treatment of metastatic prostate cancer patients

Optimisation of quality of life in patients with prostate cancerПодробнее

Optimisation of quality of life in patients with prostate cancer

Navigating #ProstateCancer: Expert Tips on Choosing the Best Prostate Cancer Care | #MarkScholzMDПодробнее

Navigating #ProstateCancer: Expert Tips on Choosing the Best Prostate Cancer Care | #MarkScholzMD

Involving the patient as expert on quality of life | Art Vreugdenhil | TEDxEindhovenSalonПодробнее

Involving the patient as expert on quality of life | Art Vreugdenhil | TEDxEindhovenSalon

Quality of Life after Treatment of Localised Prostate CancerПодробнее

Quality of Life after Treatment of Localised Prostate Cancer

UROwebinar: Adverse events and toxicity management of mPCa patients from an MDT perspectiveПодробнее

UROwebinar: Adverse events and toxicity management of mPCa patients from an MDT perspective

Lutetium-177–PSMA-617 improves self-reported pain and HRQoL in taxane-naïve patients with PSMA-p...Подробнее

Lutetium-177–PSMA-617 improves self-reported pain and HRQoL in taxane-naïve patients with PSMA-p...

The #RTIRE Trial is now recruiting patients with intermediate-risk prostate cancer.Подробнее

The #RTIRE Trial is now recruiting patients with intermediate-risk prostate cancer.

High-Intensity Focused Ultrasound (HIFU) for Prostate Cancer: First US StudyПодробнее

High-Intensity Focused Ultrasound (HIFU) for Prostate Cancer: First US Study

Does Prostate Cancer COME BACK after TREATMENT? #shortsПодробнее

Does Prostate Cancer COME BACK after TREATMENT? #shorts